Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 440 publications.

Anderson IM, Jones S, Twiss J. Do negative cognitive style and personality predict depression symptoms and functional outcomes in severe bipolar and unipolar disorders? Int J Cogn Ther. 2009 Dec 15;2(4):343-53. doi: 10.1521/ijct.2009.2.4.343

Sherrill B, Amonkar M, Sherif B, Maltzman J, O'Rourke L, Johnston S. An exploration of the association of qol scores with tumor progression status in first-line hr+, her2+ mbc patients treated with lapatinib plus letrozole or letrozole alone. Poster presented at the 32nd San Antoniio Breast Cancer Symposium Annual Meeting; December 14, 2009.

Furr B. QA influence: tips for empowerment in today's business climate. Presented at the 2009 North Carolina Chapter of the Society of Quality Assurance; December 4, 2009. Raleigh, NC.

Hoerger TJ, Zhang P, Segel JE, Gregg EW, Venkat Narayan KM, Hicks KA. Improvements in risk factor control among persons with diabetes in the United States: evidence and implications for remaining life expectancy. Diabetes Res Clin Pract. 2009 Dec 1;86(3):225-32.

Sherrill B, Amonkar MM, Sherif BN, Maltzman J, O'Rourke L, Johnston S. An exploration of the association of Quality-of-Life (QOL) scores with tumor progression status in first line hormone receptor positive, HER2+ Metastatic Breast Cancer (MBC) patients treated with lapatinib plus letrozole or letrozole alone. Poster presented at the Thirty-Second Annual CTRC‐AACR San Antonio Breast Cancer Symposium; December 2009. San Antonio, TX. [abstract] Cancer Res. 2009 Dec; 69(24 (Suppl)):5106. doi: 10.1158/0008-5472.SABCS-09-5106

Van Houtven G, Poulos C. Valuing welfare impacts of beach erosion: an application of the structural benefit transfer method. Am J Agric Econ. 2009 Dec 1;91(5):1343-50.

Mangel AW. The FDA and IBS drug development. Am J Gastroenterol. 2009 Dec 1;104(12):3106. doi: 10.1038/ajg.2009.445

Hoyo C, Schildkraut JM, Murphy SK, Chow WH, Vaughan TL, Risch H, Marks JR, Jirtle RL, Calingaert B, Mayne S, Fraumeni, Jr. J, Gammon MD. IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas. Int J Cancer. 2009 Dec 1;125(11):2673-8.

Johannes CB, Clayton AH, Odom DM, Rosen RC, Russo PA, Shifren JL, Monz BU. Distressing sexual problems in United States women revisited: prevalence after accounting for depression. J Clin Psychiatry. 2009 Dec 1;70(12):1698-706.

Castellsague J, Holick CN, Hoffman CC, Gimeno V, Stang MR, Perez-Gutthann S. Risk of upper gastrointestinal complications associated with cyclooxygenase-2 selective and nonselective nonsteroidal antiinflammatory drugs. Pharmacotherapy. 2009 Dec;29(12):1397-407. doi: 10.1592/phco.29.12.1397

Debanjali M, Hodgkins P, Yen L, Solomon D, Davis KL, Cohen R. Adherence with oral 5-aminosalicylic acid therapy in patients with ulcerative colitis: impact on all-cause healthcare costs. Inflamm Bowel Dis. 2009 Dec 1;15(12):S32.

Marshall DA, Johnson FR, Kulin NA, Ozdemir S, Walsh JME, Marshall JK, Van Bebber S, Phillips KA. How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey. Health Econ. 2009 Dec 1;18(12):1420-39.

Jayachandran A, Konigshoff M, Yu H, Rupniewska E, Hecker M, Klpetko W, Seeger W, Eickelberg O. SNAI transcription factors mediate epithelial-mesenchymal transition in lung fibrosis. Thorax. 2009 Dec;64(12):1053-61.

Shirley DG, Vekaria RM, Sevigny J. Ectonucleotidases in the kidney. Purinergic Signal. 2009 Dec;5(4):501-11. doi: 10.1007/s11302-009-9152-4

Zinner N, Noe L, Rasouliyan L, Marshall T, Runken MC, Seifeldin R. Impact of solifenacin on quality of life, medical care use, work productivity, and health utility in the elderly: an exploratory subgroup analysis. Am J Geriatr Pharmacother. 2009 Dec;7(6):373-82. doi: 10.1016/j.amjopharm.2009.11.004

Lester T, Wang JM, Bourne P, Yang Q, Fu L, Tang P. Different panels of markers should be used to predict mammary paget's disease associated with in situ or invasive ductal carcinoma of the breast. Ann Clin Lab Sci. 2009 Dec 1;39(1):17-24.

Chan KS, Chen W, Gan TJ, Hsieh R, Chen C, Lakshminararyanan M, Revicki DA. Development and validation of a composite score based on clinically meaningful events for the opioid-related symptom distress scale. Qual Life Res. 2009 Dec;18(10):1331-40.

Spiegel B, Camilleri M, Bolus R, Andresen V, Chey WD, Fehnel S, Mangel A, Talley NJ, Whitehead WE. Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome foundation report. Gastroenterology. 2009 Dec 1;137(6):1944-53.

Carr SM, Jang W. Hub arc selection for freight consolidation.. Poster presented at the IEEE Conference on Industrial Engineering and Engineering Management; December 2009.

Chatzi L, Plana E, Pappas A, Alegkakis D, Karakosta P, Daraki V. The metabolic syndrome in early pregnancy and risk of gestational diabetes mellitus. Diabetes Metab. 2009 Dec;35(6):490-4.

Johnson FR. Patient and Physician Benefit-Risk Preferences: evidence From 7 Studies. Poster presented at the DIA Conference on Assessing Benefits and Risks of Medicinal Products in Regulatory Decisions; November 20, 2009.

Johnson FR. Stated Benefit-Risk Tradeoff Preferences From Conjoint Analysis. Poster presented at the DIA Conference on Assessing Benefits and Risks of Medicinal Products in Regulatory Decisions; November 20, 2009.

Candrilli SD, O'Brien SH, Ware RE, Nahata MC, Seiber EE, Balkrishnan R. Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease. Poster presented at the 51st American Society of Hematology (ASH) Annual Meeting and Exposition; December 5, 2009. New Orleans, LA. [abstract] Blood. 2009 Nov 20; 114(22):2483. doi: 10.1182/blood.V114.22.2483.2483

Yong M, Schoonen WM, Li L, Kaye JA. A comparison of the sex-specific incidence of Immune thrombocytopenia in children, teenagers, and adults in the general practice research database. Poster presented at the 51st American Society of Hematology (ASH) Annual Meeting and Exposition; December 2009. New Orleans, LA. [abstract] Blood. 2009 Nov 20; 114(22):3502. doi: 10.1182/blood.V114.22.3502.3502

Wolowacz S. The United Kingdom's national institute for health and clinical excellence: new developments. Poster presented at the 2009 ISPOR 12th Annual European Congress; November 19, 2009.

Lloyd A, Bridges JFP, Johnson FR. Classifying patient reported outcomes: developments in the field suggest a new taxonomy. Poster presented at the 2009 ISPOR 12th Annual European Congress; November 16, 2009.

Faulkner EC. The Devil is in the Details: international Comparison of Technology Assessment Processes and Payer Uptake of Personalized Medicine and Implications for the Field. Poster presented at the 2009 ISPOR 12th Annual European Congress; November 16, 2009.

Rycroft CE, Beard S, Leeuwenkamp O, Moren S. Burden of Paediatric Influenza in Europe: a Gap Analysis. Poster presented at the 2009 ISPOR 12th Annual European Congress; November 16, 2009.

Tennis P, Andrews E, Ambrose C, Toback S, Rousculp MD. A postmarketing commitment to evaluate the frequency of use and safety of live attenuated influenza vaccine use in non-recommended populations less than 59 months of age. Poster presented at the 47th Annual Meeting of the Infectious Diseases Society of America; November 3, 2009.

Zarkin GA, Cowell AJ, Dunlap LJ, Hicks KA, Keyes VS, Mills MJ. Benefits and costs of alternative substance abuse treatment programs for individuals in state prisons: results from a lifetime simulation model. Presented at the American Society of Criminology Annual Meeting; November 2009. Previously presented at the Addiction Health Services Research Annual conference.

Cowell AJ, Zarkin GA, Dunlap LJ, Hicks KA, Keyes VS, Mills MJ. Findings on drug use, crime, arrests, and other model outcomes from a simulation model of prison-based substance abuse treatment. Presented at the American Society of Criminology Annual Meeting; November 2009.

Ferreira-Gonzalez I, Marsal JR, Mitjavila F, Parada A, Ribera A, Cascant P, Soriano N, Sanchez PL, Aros F, Heras M, Bueno H, Marrugat J, Cunat J, Civeira E, Permanyer-Miralda G. Patient registries of acute coronary syndrome: assessing or biasing the clinical real world data? Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):540-7. doi: 10.1161/CIRCOUTCOMES.108.844399

Talbird SE, Brogan AJ, Winiarski AP. Oseltamivir for influenza postexposure prophylaxis: economic evaluation for children aged 1-12 years in the U.S. Am J Prev Med. 2009 Nov 1;37(5):381-8.

Juniper M, Le TK, Mladsi D. The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review. Expert Opin Pharmacother. 2009 Nov 1;10(16):2581-92. doi: 10.1517/14656560903304063.

Smets E, Stoll M, Hill A, Soorapanth S, Donatz V, Brogan AJ. Comparative cost-efficacy analysis of darunavir/r and other ritonavir-boosted protease inhibitors for first-line treatment of HIV-1 infection in Germany. Poster presented at the 12th European AIDS Conference/EACS; November 2009.

Oglesby A, Sherif B, Odom D, Leahy M, Qian Y. Time and costs associated with preparing and administering zoledronic acid in patients with breast or prostate cancer and metastatic bone disease. Community Oncol. 2009 Nov 1;6(11):494-502.

Foster T, Brown TM, Chang J, Menssen HD, Blieden MB, Herzog TJ. A review of the current evidence for maintenance therapy in ovarian cancer. Gynecol Oncol. 2009 Nov 1;115:290-301.

Delong RK, Akhtar U, Sallee M, Parker B, Barber S, Zhang J, Craig M, Garrad R, Hickey AJ, Engstrom E. Characterization and performance of nucleic acid nanoparticles combined with protamine and gold. Biomaterials. 2009 Nov 1;30(32):6451-9.

Zeiger RS, Chipps BE, Haselkorn T, Rasouliyan L, Simons FE, Fish JE. Comparison of asthma exacerbations in pediatric and adult patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2009 Nov;124(5):1106-8. doi: 10.1016/j.jaci.2009.07.052

Sheehan WJ, Baxi SN, Hoffman EB, Gold DR, Phipatanakul W. Endotoxin levels in inner-city schools compared to students' homes. Presented at the 2009 ACAAI; November 2009. Miami, FL.

Mast TC, Zhu XS, Demuro-Mercon C, Cummings HW, Sings HL, Ferris DG. Development and psychometric properties of the HPV Impact Profile (HIP) to assess the psychosocial burden of HPV. Curr Med Res Opin. 2009 Nov 1;25(11):2609-19.

Mansfield CA, Viswanathan M, Woodell CL, Rojas Smith L, Darcy NM, Ohadike Y. Assessing outcomes from the Merck childhood asthma network (MCAN): challenges and results. Presented at the Annual Meeting of the American Public Health Association; November 2009. Philadelphia, PA.

Jackel J, Davis KL, Patel A. Stroke in the long-term care setting: patient characteristics and medication treatment. Poster presented at the Annual Meeting of the American Society of Consultant Pharmacists; November 2009.

Jackel J, Davis KL, Patel A. TIA in the long-term care setting: patient characteristics and medication treatment. Poster presented at the Annual Meeting of the American Society of Consultant Pharmacists; November 2009.

Naslund M, Eaddy MT, Hogue SL, Kruep EJ, Shah MB. Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery.. Curr Med Res Opin. 2009 Nov;25(11):2663-9. doi: 10.1185/03007990903210330.

Ness RobertaB, Andrews EB, Gaudino JamesA, Newman AnneB, Soskolne ColinL, Stürmer Til, Wartenber DanielE, Weiss StanleyH. The future of epidemiology. Acad Med. 2009 Nov;84(11):1631-7.

Mehta S, Nagar SP, Aparasu R. Unmet prescription medication need in U.S. children. J Am Pharm Assoc. 2009 Nov;49(6):769-76.

Varas-Lorenzo C, Castellsaque J, Stang MR, Perez-Gutthann S, Aguado J, Rodriguez LA. The use of selective cyclooxygenase-2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada. Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1016-25.

Sunyer J, Forastiere F, Pekkanen J, Plana E, Kolz M, Pistelli R. Interaction between smoking and the interleukin-6 gene affects systemic levels of inflammatory biomarkers. Nicotine Tob Res. 2009 Nov;11(11):1347-53.

Fehnel S. Establishing optimal requirements for content validity: a work in progress. Value Health. 2009 Nov 1;12(8):1074.